PMID- 34608499 OWN - NLM STAT- MEDLINE DCOM- 20220124 LR - 20220124 IS - 1791-3004 (Electronic) IS - 1791-2997 (Print) IS - 1791-2997 (Linking) VI - 24 IP - 6 DP - 2021 Dec TI - Astaxanthin induces NADPH oxidase activation and receptor‑interacting protein kinase 1‑mediated necroptosis in gastric cancer AGS cells. LID - 837 [pii] LID - 10.3892/mmr.2021.12477 [doi] AB - Astaxanthin (ASX), a red‑colored xanthophyll carotenoid, functions as an antioxidant or pro‑oxidant. ASX displays anticancer effects by reducing or increasing oxidative stress. Reactive oxygen species (ROS) promote cancer cell death by necroptosis mediated by receptor‑interacting protein kinase 1 (RIP1) and RIP3. NADPH oxidase is a major source of ROS that may promote necroptosis in some cancer cells. The present study aimed to investigate whether ASX induces necroptosis by increasing NADPH oxidase activity and ROS levels in gastric cancer AGS cells. AGS cells were treated with ASX with or without ML171 (NADPH oxidase 1 specific inhibitor), N‑acetyl cysteine (NAC; antioxidant), z‑VAD (pan‑caspase inhibitor) or Necrostatin‑1 (Nec‑1; a specific inhibitor of RIP1). As a result, ASX increased NADPH oxidase activity, ROS levels and cell death, and these effects were suppressed by ML171 and NAC. Furthermore, ASX induced RIP1 and RIP3 activation, ultimately inducing mixed lineage kinase domain‑like protein (MLKL) activation, lactate dehydrogenase (LDH) release and cell death. Moreover, the ASX‑induced decrease in cell viability was reversed by Nec‑1 treatment and RIP1 siRNA transfection, but not by z‑VAD. ASX did not increase the ratio of apoptotic Bax/anti‑apoptotic Bcl‑2, the number of Annexin V‑positive cells, or caspase‑9 activation, which are apoptosis indices. In conclusion, ASX induced necroptotic cell death by increasing NADPH oxidase activity, ROS levels, LDH release and the number of propidium iodide‑positive cells, as well as activating necroptosis‑regulating proteins, RIP1/RIP3/MLKL, in gastric cancer AGS cells. The results of this study demonstrated the necroptotic effect of ASX on gastric cancer AGS cells, which required NADPH oxidase activation and RIP1/RIP3/MLKL signaling in vitro. FAU - Kim, Sori AU - Kim S AD - Department of Food and Nutrition, Brain Korea 21 FOUR Project, College of Human Ecology, Yonsei University, Seoul 03722, Republic of Korea. FAU - Lee, Hanbit AU - Lee H AD - Department of Food and Nutrition, Brain Korea 21 FOUR Project, College of Human Ecology, Yonsei University, Seoul 03722, Republic of Korea. FAU - Lim, Joo Weon AU - Lim JW AD - Department of Food and Nutrition, Brain Korea 21 FOUR Project, College of Human Ecology, Yonsei University, Seoul 03722, Republic of Korea. FAU - Kim, Hyeyoung AU - Kim H AD - Department of Food and Nutrition, Brain Korea 21 FOUR Project, College of Human Ecology, Yonsei University, Seoul 03722, Republic of Korea. LA - eng PT - Journal Article DEP - 20211005 PL - Greece TA - Mol Med Rep JT - Molecular medicine reports JID - 101475259 RN - 0 (Antitubercular Agents) RN - 0 (Imidazoles) RN - 0 (Indoles) RN - 0 (Reactive Oxygen Species) RN - 0 (Xanthophylls) RN - 0 (necrostatin-1) RN - 8XPW32PR7I (astaxanthine) RN - EC 1.1.1.27 (L-Lactate Dehydrogenase) RN - EC 1.6.3.- (NADPH Oxidases) RN - EC 2.7.- (MLKL protein, human) RN - EC 2.7.- (Protein Kinases) RN - EC 2.7.11.1 (RIPK1 protein, human) RN - EC 2.7.11.1 (Receptor-Interacting Protein Serine-Threonine Kinases) SB - IM MH - Adenocarcinoma/metabolism MH - Animals MH - Antitubercular Agents/pharmacology MH - Apoptosis MH - Cell Death MH - Cell Line, Tumor MH - Epithelial Cells MH - Humans MH - Imidazoles MH - Indoles MH - L-Lactate Dehydrogenase/metabolism MH - NADPH Oxidases/drug effects/*metabolism MH - *Necroptosis MH - Protein Kinases/metabolism MH - Rats MH - Reactive Oxygen Species/*metabolism MH - Receptor-Interacting Protein Serine-Threonine Kinases/*metabolism MH - Stomach Neoplasms/*metabolism MH - Xanthophylls/pharmacology PMC - PMC8503742 OTO - NOTNLM OT - NADPH oxidase OT - astaxanthin OT - gastric cancer cells OT - reactive oxygen species OT - receptor interacting protein kinase 1 COIS- The authors declare that they have no competing interests. EDAT- 2021/10/06 06:00 MHDA- 2022/01/27 06:00 PMCR- 2021/10/04 CRDT- 2021/10/05 06:42 PHST- 2021/07/21 00:00 [received] PHST- 2021/09/22 00:00 [accepted] PHST- 2021/10/05 06:42 [entrez] PHST- 2021/10/06 06:00 [pubmed] PHST- 2022/01/27 06:00 [medline] PHST- 2021/10/04 00:00 [pmc-release] AID - 837 [pii] AID - MMR-24-06-12477 [pii] AID - 10.3892/mmr.2021.12477 [doi] PST - ppublish SO - Mol Med Rep. 2021 Dec;24(6):837. doi: 10.3892/mmr.2021.12477. Epub 2021 Oct 5.